BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Calviño-Suárez C, Ferreiro-Iglesias R, Bastón-Rey I, Barreiro-de Acosta M. Role of Quality of Life as Endpoint for Inflammatory Bowel Disease Treatment. Int J Environ Res Public Health 2021;18:7159. [PMID: 34281095 DOI: 10.3390/ijerph18137159] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Ramos L, Teo-Loy J, Barreiro-de Acosta M. Disease clearance in ulcerative colitis: Setting the therapeutic goals for future in the treatment of ulcerative colitis. Front Med (Lausanne) 2022;9:1102420. [PMID: 36698823 DOI: 10.3389/fmed.2022.1102420] [Reference Citation Analysis]
2 Kawakami A, Tanaka M, Sakagami K, Choong LM, Kunisaki R, Maeda S, Bjarnason I, Ito H, Hayee B. Daily life difficulties among patients with ulcerative colitis in Japan and the United Kingdom: A comparative study. Medicine 2022;101:e30216. [DOI: 10.1097/md.0000000000030268] [Reference Citation Analysis]
3 You L, Guo N, Wang T, Yu X, Kang X, Guan Y, Liu H, Dong J, Bian P, Wang S, Bai C. Effects of aromatherapy on fatigue, quality of sleep and quality of life in patients with inflammatory bowel disease: A feasibility study. Complementary Therapies in Clinical Practice 2022. [DOI: 10.1016/j.ctcp.2022.101648] [Reference Citation Analysis]
4 Jun S, Jie L, Ren M, Zhihua R. Secondary Indicators for an Evaluation and Guidance System for Quality of Care in Inflammatory Bowel Disease Centers: A Critical Review of the Inflammatory Bowel Disease Quality of Care Center. Inflamm Bowel Dis 2022;28:S3-8. [PMID: 35247049 DOI: 10.1093/ibd/izac009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Stroie T, Preda C, Meianu C, Croitoru A, Gheorghe L, Gheorghe C, Diculescu M. Health-Related Quality of Life in Patients with Inflammatory Bowel Disease in Clinical Remission: What Should We Look For? Medicina 2022;58:486. [DOI: 10.3390/medicina58040486] [Reference Citation Analysis]
6 Jordi SBU, Lang BM, Wyss J, Auschra B, Yilmaz B, Krupka N, Greuter T, Schreiner P, Biedermann L, Preisig M, von Känel R, Rogler G, Begré S, Misselwitz B; Swiss IBD cohort study group. The personality traits activity, self-reproach, and negative affect jointly predict clinical recurrence, depressive symptoms, and low quality of life in inflammatory bowel disease patients. J Gastroenterol 2022;57:848-66. [PMID: 35900592 DOI: 10.1007/s00535-022-01902-7] [Reference Citation Analysis]
7 Koliouli F, Issari P, Mitrou A. Lived experiences of Idiopathic Inflammatory Bowel Disease (IBD) patients and the perceived impact of the COVID-19 pandemic. J Health Psychol 2021;:13591053211059382. [PMID: 34875898 DOI: 10.1177/13591053211059382] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]